Objective:
To accelerate the development and commercialization of AI tools for eye care and oculomics.
Approach:
- Funding and Partnerships: Cascader completed a seed funding round led by Topcon Healthcare, formed through a partnership with Moorfields Eye Hospital NHS Foundation Trust and UCL Ventures.
- Product Development: The funding will support the progression of its first products, focusing on macular diseases, particularly age-related macular degeneration (AMD).
- Broader AI Applications: Cascader plans to develop a portfolio of AI tools for community optometry, high-street settings, and specialist clinics, applying ocular imaging to systemic conditions.
- Research Foundation: The company builds on over a decade of AI research at the UCL Institute of Ophthalmology and Moorfields, including a collaboration with Google DeepMind.
- Support Infrastructure: Cascader will receive support from the INSIGHT Eye and Oculomics Health Data Research Hub at Moorfields for AI development.
Key Findings:
- Cascader aims to translate AI from research into routine clinical care.
- The initial focus is on macular diseases, with plans for broader applications.
- The company leverages over a decade of AI research and collaboration with Google DeepMind.
Conclusion:
Cascader is transitioning from research to scalable clinical applications in eye care.
Sources:
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
